Search Results - "Hu, Quanyin"

Refine Results
  1. 1

    Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook by Wang, Chao, Ye, Yanqi, Hu, Quanyin, Bellotti, Adriano, Gu, Zhen

    Published in Advanced materials (Weinheim) (01-08-2017)
    “…Cancer immunotherapy, as a paradigm shift in cancer treatment, has recently received tremendous attention. The active cancer vaccination, immune checkpoint…”
    Get full text
    Journal Article
  2. 2

    Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment by Li, Zhaoting, Ding, Yingyue, Liu, Jun, Wang, Jianxin, Mo, Fanyi, Wang, Yixin, Chen-Mayfield, Ting-Jing, Sondel, Paul M., Hong, Seungpyo, Hu, Quanyin

    Published in Nature communications (06-04-2022)
    “…Immunosuppressive cells residing in the tumor microenvironment, especially tumor associated macrophages (TAMs), hinder the infiltration and activation of T…”
    Get full text
    Journal Article
  3. 3

    Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation by Chen, Yu, Tandon, Ira, Heelan, William, Wang, Yixin, Tang, Weiping, Hu, Quanyin

    Published in Chemical Society reviews (04-07-2022)
    “…Proteolysis Targeting Chimeras (PROTACs), an emerging therapeutic entity designed to degrade target proteins by hijacking the ubiquitin-proteasome system, have…”
    Get more information
    Journal Article
  4. 4

    Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy by Ding, Yingyue, Wang, Yixin, Hu, Quanyin

    Published in Exploration (Beijing, China) (01-06-2022)
    “…Immunotherapy strategies that use cell‐based delivery systems have sparked much interest in the treatment of malignancies, owing to their high…”
    Get full text
    Journal Article
  5. 5

    Anticancer Platelet-Mimicking Nanovehicles by Hu, Quanyin, Sun, Wujin, Qian, Chengen, Wang, Chao, Bomba, Hunter N., Gu, Zhen

    Published in Advanced materials (Weinheim) (25-11-2015)
    “…A core–shell nanovehicle coated with a platelet membrane (PM) is developed for targeted and site‐specific delivery of an extracellularly active drug and an…”
    Get full text
    Journal Article
  6. 6

    Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing by Sun, Wujin, Ji, Wenyan, Hall, Jordan M., Hu, Quanyin, Wang, Chao, Beisel, Chase L., Gu, Zhen

    Published in Angewandte Chemie International Edition (05-10-2015)
    “…CRISPR–Cas9 represents a promising platform for genome editing, yet means for its safe and efficient delivery remain to be fully realized. A novel vehicle that…”
    Get full text
    Journal Article
  7. 7

    Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke by Xu, Jianpei, Wang, Xiaoqi, Yin, Haoyuan, Cao, Xiang, Hu, Quanyin, Lv, Wei, Xu, Qunwei, Gu, Zhen, Xin, Hongliang

    Published in ACS nano (27-08-2019)
    “…Ischemic stroke caused by a thrombus clog and ischemia is one of the most lethal and disabling cerebrovascular diseases. A sequentially targeted delivery…”
    Get full text
    Journal Article
  8. 8

    Shape-controlled synthesis of liquid metal nanodroplets for photothermal therapy by Yan, Junjie, Zhang, Xudong, Liu, Yang, Ye, Yanqi, Yu, Jicheng, Chen, Qian, Wang, Jinqiang, Zhang, Yuqi, Hu, Quanyin, Kang, Yang, Yang, Min, Gu, Zhen

    Published in Nano research (01-06-2019)
    “…The capping agents for liquid metal (LM) nanodroplets in aqueous solutions are restricted to thiol-containing and positively-charged molecules or…”
    Get full text
    Journal Article
  9. 9

    Light-Activated Hypoxia-Responsive Nanocarriers for Enhanced Anticancer Therapy by Qian, Chenggen, Yu, Jicheng, Chen, Yulei, Hu, Quanyin, Xiao, Xuanzhong, Sun, Wujin, Wang, Chao, Feng, Peijian, Shen, Qun-Dong, Gu, Zhen

    Published in Advanced materials (Weinheim) (01-05-2016)
    “…A light‐activated hypoxia‐responsive conjugated polymer‐based nanocarrier is developed for efficiently producing singlet oxygen (1O2) and inducing hypoxia to…”
    Get full text
    Journal Article
  10. 10

    Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response by Li, Zhaoting, Mo, Fanyi, Wang, Yixin, Li, Wen, Chen, Yu, Liu, Jun, Chen-Mayfield, Ting-Jing, Hu, Quanyin

    Published in Nature communications (24-10-2022)
    “…Pore-forming Gasdermin protein-induced pyroptosis in tumor cells promotes anti-tumor immune response through the release of pro-inflammatory cytokines and…”
    Get full text
    Journal Article
  11. 11

    PD‐1 Blockade Cellular Vesicles for Cancer Immunotherapy by Zhang, Xudong, Wang, Chao, Wang, Jinqiang, Hu, Quanyin, Langworthy, Benjamin, Ye, Yanqi, Sun, Wujin, Lin, Jing, Wang, Tianfu, Fine, Jason, Cheng, Hao, Dotti, Gianpietro, Huang, Peng, Gu, Zhen

    Published in Advanced materials (Weinheim) (01-05-2018)
    “…Cancer cells resist to the host immune antitumor response via multiple suppressive mechanisms, including the overexpression of PD‐L1 that exhausts…”
    Get full text
    Journal Article
  12. 12

    Transformable liquid-metal nanomedicine by Lu, Yue, Hu, Quanyin, Lin, Yiliang, Pacardo, Dennis B., Wang, Chao, Sun, Wujin, Ligler, Frances S., Dickey, Michael D., Gu, Zhen

    Published in Nature communications (02-12-2015)
    “…To date, numerous inorganic nanocarriers have been explored for drug delivery systems (DDSs). However, the clinical application of inorganic formulations has…”
    Get full text
    Journal Article
  13. 13

    In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy by Wang, Chao, Sun, Wujin, Ye, Yanqi, Hu, Quanyin, Bomba, Hunter N., Gu, Zhen

    Published in Nature biomedical engineering (01-02-2017)
    “…Cancer recurrence after surgical resection remains a significant challenge in cancer therapy. Platelets, which accumulate in wound sites and interact with…”
    Get full text
    Journal Article
  14. 14

    Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets by Hu, Quanyin, Li, Hongjun, Archibong, Edikan, Chen, Qian, Ruan, Huitong, Ahn, Sarah, Dukhovlinova, Elena, Kang, Yang, Wen, Di, Dotti, Gianpietro, Gu, Zhen

    Published in Nature biomedical engineering (01-09-2021)
    “…The immunosuppressive microenvironment of solid tumours reduces the antitumour activity of chimeric antigen receptor T cells (CAR-T cells). Here, we show that…”
    Get full text
    Journal Article
  15. 15

    Chiral Supraparticles for Controllable Nanomedicine by Yeom, Jihyeon, Guimaraes, Pedro P. G., Ahn, Hyo Min, Jung, Bo‐Kyeong, Hu, Quanyin, McHugh, Kevin, Mitchell, Michael J., Yun, Chae‐Ok, Langer, Robert, Jaklenec, Ana

    Published in Advanced materials (Weinheim) (01-01-2020)
    “…Chirality is ubiquitous in nature and hard‐wired into every biological system. Despite the prevalence of chirality in biological systems, controlling…”
    Get full text
    Journal Article
  16. 16

    Convergence of nanomedicine and neutrophils for drug delivery by Yuan, Sichen, Hu, Quanyin

    Published in Bioactive materials (01-05-2024)
    “…Neutrophils have recently emerged as promising carriers for drug delivery due to their unique properties including rapid response toward inflammation,…”
    Get full text
    Journal Article
  17. 17

    Anaerobe‐Inspired Anticancer Nanovesicles by Qian, Chenggen, Feng, Peijian, Yu, Jicheng, Chen, Yulei, Hu, Quanyin, Sun, Wujin, Xiao, Xuanzhong, Hu, Xiuli, Bellotti, Adriano, Shen, Qun‐Dong, Gu, Zhen

    Published in Angewandte Chemie International Edition (01-03-2017)
    “…Anaerobic bacteria, such as Clostridium and Salmonella, can selectively invade and colonize in tumor hypoxic regions (THRs) and deliver therapeutic products to…”
    Get full text
    Journal Article
  18. 18

    Bio‐Orthogonal Chemistry in Cell Engineering by Wang, Yixin, Hu, Quanyin

    Published in Advanced NanoBiomed Research (Online) (01-03-2023)
    “…Cell therapy holds great promise in addressing a wide range of malignant diseases, such as cancers and infectious diseases. The convergence of chemistry,…”
    Get full text
    Journal Article
  19. 19

    Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy by Hu, Quanyin, Sun, Wujin, Wang, Jinqiang, Ruan, Huitong, Zhang, Xudong, Ye, Yanqi, Shen, Song, Wang, Chao, Lu, Weiyue, Cheng, Ke, Dotti, Gianpietro, Zeidner, Joshua F., Wang, Jun, Gu, Zhen

    Published in Nature biomedical engineering (01-11-2018)
    “…Patients with acute myeloid leukaemia who relapse following therapy have few treatment options and face poor outcomes. Immune checkpoint inhibition, for…”
    Get full text
    Journal Article
  20. 20

    Dual targeted nanocarrier for brain ischemic stroke treatment by Zhao, Yue, Jiang, Yan, Lv, Wei, Wang, Zhongyuan, Lv, Lingyan, Wang, Baoyan, Liu, Xin, Liu, Yang, Hu, Quanyin, Sun, Wujin, Xu, Qunwei, Xin, Hongliang, Gu, Zhen

    Published in Journal of controlled release (10-07-2016)
    “…Focal cerebral ischemia, known as stroke, causes serious long-term disabilities globally. Effective therapy for cerebral ischemia demands a carrier that can…”
    Get full text
    Journal Article